News headlines about Ekso Bionics Holdings (NASDAQ:EKSO) have been trending somewhat positive this week, Accern Sentiment reports. The research group identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Ekso Bionics Holdings earned a news impact score of 0.14 on Accern’s scale. Accern also gave news stories about the company an impact score of 46.2137636358568 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
Here are some of the news stories that may have effected Accern’s rankings:
- Small Cap Stock in Focus: Ekso Bionics Holdings, Inc. (:EKSO … – FLBC News (flbcnews.com)
- Russ Angold Sells 28,254 Shares of Ekso Bionics Holdings, Inc. (EKSO) Stock (americanbankingnews.com)
- Ekso Bionics reports second-quarter earnings – Healio – Healio (healio.com)
- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Files An 8-K Financial Statements and Exhibits (4-traders.com)
Shares of Ekso Bionics Holdings (NASDAQ EKSO) traded up 1.95% during midday trading on Friday, hitting $1.57. The stock had a trading volume of 260,028 shares. The stock’s market cap is $40.49 million. The firm’s 50-day moving average price is $1.89 and its 200-day moving average price is $2.55. Ekso Bionics Holdings has a 1-year low of $0.99 and a 1-year high of $6.38.
Several brokerages have recently weighed in on EKSO. B. Riley reissued a “buy” rating and issued a $4.00 price target on shares of Ekso Bionics Holdings in a research note on Monday, May 15th. Zacks Investment Research raised Ekso Bionics Holdings from a “hold” rating to a “buy” rating and set a $2.00 price target for the company in a research note on Wednesday, July 26th.
COPYRIGHT VIOLATION WARNING: “Ekso Bionics Holdings (EKSO) Earns Media Impact Score of 0.14” was first reported by BNB Daily and is owned by of BNB Daily. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The original version of this piece can be read at https://www.baseball-news-blog.com/2017/08/19/ekso-bionics-holdings-ekso-earning-somewhat-favorable-press-coverage-report-finds-updated.html.
In related news, insider Russ Angold sold 221,746 shares of Ekso Bionics Holdings stock in a transaction on Tuesday, August 15th. The stock was sold at an average price of $1.55, for a total transaction of $343,706.30. Following the sale, the insider now directly owns 400,678 shares in the company, valued at $621,050.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 7.10% of the stock is owned by company insiders.
Receive News & Ratings for Ekso Bionics Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.